PatSnap/drug-approvals

药物批准与监管时间线数据集包含来自四个主要监管辖区（中国NMPA、美国FDA、欧盟EMA和日本PMDA）的500个药物批准记录，每个地区约100条记录。该数据集支持全球药物批准情况的比较监管分析和时间建模。关键特征包括：四辖区覆盖（中国、美国、欧盟和日本的平衡代表，用于跨区域监管研究）、时间监管跟踪（包括首次批准日期first_approval_date和详细时间戳跟踪time_ts）以及实体链接（将批准映射到特定的drug_id、disease_id和组织实体org_master_entity_id）。

The Pharmaceutical Approvals & Regulatory Timeline Data captures 500 drug approval records drawn from the four major regulatory jurisdictions: China (NMPA), United States (FDA), European Union (EMA), and Japan (PMDA), with approximately 100 records per region. It enables comparative regulatory analysis and temporal modeling of the global pharmaceutical approval landscape. Key Features: Four-Jurisdiction Coverage (Balanced representation across China, US, EU, and Japan for cross-regional regulatory research), Temporal Regulatory Tracking (Includes first_approval_date and detailed timestamp tracking time_ts), and Entity Linkage (Maps approvals to specific drug_id, disease_id, and organizational entities org_master_entity_id).